Saksela O - Search Results

1

Suominen E, Jahkola T, Jeskanen L, Knuuttila E, Mustonen P, Pyrhönen S, Saksela O, Vihinen P, Osterman H. Suominen E, et al. Among authors: saksela o. Duodecim. 2006;122(17):2157-8. Duodecim. 2006. PMID: 17115634 Finnish. No abstract available.

2

[Sentinel lymph node biopsy in patients with cutaneous melanoma].

Jahkola T, Virolainen S, Leppänen E, Suominen S, Hernberg M, Hahka-Kemppinen M, Saksela O. Jahkola T, et al. Among authors: saksela o. Duodecim. 2002;118(22):2289-94. Duodecim. 2002. PMID: 12523105 Review. Finnish. No abstract available.

3

[Regulation of melanoma growth].

Paloheimo M, Saksela O, Pyrhönen S, Alitalo K. Paloheimo M, et al. Among authors: saksela o. Duodecim. 1992;108(23-24):2097-104. Duodecim. 1992. PMID: 1345291 Review. Finnish. No abstract available.

4

Melanoma on tattoos: two Finnish cases.

Kluger N, Koskenmies S, Jeskanen L, Övermark M, Saksela O. Kluger N, et al. Among authors: saksela o. Acta Derm Venereol. 2014 May;94(3):325-6. doi: 10.2340/00015555-1705. Acta Derm Venereol. 2014. PMID: 24096729 Free article. No abstract available.

5

MMP-21 is upregulated at early stages of melanoma progression but disappears with more aggressive phenotype.

Kuivanen T, Ahokas K, Virolainen S, Jahkola T, Hölttä E, Saksela O, Saarialho-Kere U. Kuivanen T, et al. Among authors: saksela o. Virchows Arch. 2005 Dec;447(6):954-60. doi: 10.1007/s00428-005-0046-8. Epub 2005 Aug 20. Virchows Arch. 2005. PMID: 16133364

6

TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.

Yin M, Soikkeli J, Jahkola T, Virolainen S, Saksela O, Hölttä E. Yin M, et al. Among authors: saksela o. Am J Pathol. 2012 Dec;181(6):2202-16. doi: 10.1016/j.ajpath.2012.08.027. Epub 2012 Oct 10. Am J Pathol. 2012. PMID: 23063511 Free article.

7

Osteopontin promotes the invasive growth of melanoma cells by activating integrin αvβ3 and down-regulating tetraspanin CD9.

Yin M, Soikkeli J, Jahkola T, Virolainen S, Saksela O, Hölttä E. Yin M, et al. Among authors: saksela o. Am J Pathol. 2014 Mar;184(3):842-58. doi: 10.1016/j.ajpath.2013.11.020. Epub 2014 Jan 8. Am J Pathol. 2014. PMID: 24412090 Free article.

8

Delineating margins of lentigo maligna using a hyperspectral imaging system.

Neittaanmäki-Perttu N, Grönroos M, Jeskanen L, Pölönen I, Ranki A, Saksela O, Snellman E. Neittaanmäki-Perttu N, et al. Among authors: saksela o. Acta Derm Venereol. 2015 May;95(5):549-52. doi: 10.2340/00015555-2010. Acta Derm Venereol. 2015. PMID: 25394551 Free article.

9

Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls.

Eriksson J, Le Joncour V, Jahkola T, Juteau S, Laakkonen P, Saksela O, Hölttä E. Eriksson J, et al. Among authors: saksela o. Mol Oncol. 2020 Apr;14(4):742-762. doi: 10.1002/1878-0261.12649. Epub 2020 Feb 28. Mol Oncol. 2020. PMID: 32053263 Free PMC article.

10

Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.

Eriksson J, Le Joncour V, Nummela P, Jahkola T, Virolainen S, Laakkonen P, Saksela O, Hölttä E. Eriksson J, et al. Among authors: saksela o. Oncotarget. 2016 Mar 22;7(12):15065-92. doi: 10.18632/oncotarget.7604. Oncotarget. 2016. PMID: 26918341 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page